Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
GAO
Senators Ask GAO to Investigate Potential Orphan Drug Act Abuse
In a March 3, 2017, letter to the United States Government Accountability Office, Senators Orrin Hatch, Chuck Grassley, and Tom…
New OIG Guidance on IRO Independence and Objectivity
In August 2016, new Health and Human Services (HHS) Office of Inspector General (OIG) guidance was issued on Independent Review…
GAO Issues Report on Generic Drug Price Increases
On September 12, 2016, the Government Accountability Office (GAO) released a report about generic drug prices in the Medicare Part…
GAO Report Harshly Critical of Medicare Advantage Plans
A May 2016 report from the United States Government Accountability Office (GAO) is harshly critical of Private Medicare Advantage…
E&C Subcommittee Hearing, HHS OIG and GAO Reports on Medicare and…
On May 24, 2016, the House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled, "Medicare and…
E&C Committee Requests Government Accountability Office Look Into…
Bipartisan leaders of the House Energy and Commerce and House Ways and Means Committees on Monday sent a letter to the Government…
Results from the First Two Years of the Pioneer Accountable Care…
On May 22, the Government Accountability Office (GAO) released a study evaluating the financial and quality outcomes for…
GAO Wants More Transparency in the How CMS Determines Medicare Payment…
The transparency movement is shining a light into most every aspect of healthcare these days. How Medicare bases its…
HHS Duplicative Databases Slows Enforcement Efforts
The Government Accountability Office (GAO) published a report highlighting the important role oversight and law enforcement…
GAO Reports Vulnerabilities in CMS Payment Oversight
In 2011, CMS estimated that Medicaid and Medicare had improper payments of $21.9 billion and almost $43 billion,…